PINC Q1 Earnings Call: Revenue Tops Estimates Amid Tariff and Margin Pressures

Healthcare tech company Premier (NASDAQ:PINC) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 8.9% year on year to $261.4 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.44 per share was 45% above analysts’ consensus estimates.

Is now the time to buy PINC? Find out in our full research report (it’s free).

StockStory’s Take

Premier’s first quarter results reflected sequential improvement in both its supply chain and performance services businesses, as management attributed the outperformance to strong contract execution, higher contract penetration, and early benefits from new talent investments. CEO Mike Alkire highlighted that health system customers are increasingly relying on Premier’s data-driven tools and supply chain expertise to manage mounting cost pressures, including labor shortages and the threat of new tariffs on medical products.

Looking ahead, management’s guidance incorporates both ongoing challenges and new opportunities. CFO Glenn Coleman pointed to continued investments in advisory services, technology, and supply chain solutions, while noting that the recently accelerated share repurchase program and dividend policy are expected to support shareholder returns. Still, management cautioned that pressures from tariffs, labor market constraints, and evolving federal healthcare policy are likely to influence customer behavior and overall demand for Premier’s services throughout the year.

Key Insights from Management’s Remarks

Premier’s leadership identified several factors influencing recent results and outlined strategic moves to navigate ongoing industry challenges. Management emphasized the role of supply chain services, technology investments, and evolving customer needs in driving both quarterly performance and the company’s competitive positioning.

• Supply Chain Services Momentum: Premier’s supply chain segment benefited from greater contract penetration with existing members and onboarding of new participants, supported by proactive strategies to address tariffs and supply chain resiliency.
• Contract Renewal Progress: The company made significant headway with group purchasing organization (GPO) contract renewals, completing negotiations for members representing over three quarters of targeted fees, which is expected to stabilize fee structures in the coming periods.
• Performance Services Rebound: Notable sequential improvement in the performance services business was attributed to new talent hires, increased enterprise license agreements, and expansion of advisory and software offerings, which have begun to rebuild the sales pipeline.
• Tariff Management Initiatives: Management discussed ongoing efforts to mitigate tariff impacts through member-led contracting, dynamic pricing models, and supply chain diversification—measures designed to limit cost pass-through to health system customers.
• Partnership and Technology Expansion: The announcement of a strategic partnership with Epic to deliver documentation and coding solutions, expected to launch in late 2025, signals a broadening of Premier’s technology-first approach to healthcare performance improvement.

Drivers of Future Performance

Management’s outlook for the remainder of the year is shaped by continued investments in core capabilities and a cautious approach to industry headwinds, with a focus on supply chain innovation and advisory service expansion as key themes.

• Ongoing Tariff and Cost Pressures: Management flagged tariffs, potential policy changes, and labor shortages as persistent uncertainties that could impact customer purchasing decisions and overall demand for Premier’s offerings.
• Advisory and Tech Investment: Premier expects growth from expanded advisory services, new technology rollouts, and its upcoming partnership with Epic, with management believing these initiatives can help healthcare providers improve margins and efficiency.
• Contract and Fee Stability: The near-completion of major contract renewals is anticipated to stabilize supply chain fee structures and support more predictable revenue from the core GPO business.

Top Analyst Questions

• Kevin Caliendo (UBS): Asked if Premier’s outperformance was due to market share gains, customer demand, or tariff anticipation. Management said it was a combination of labor, tariff, and reimbursement pressures driving providers to seek Premier’s services.
• Eric Percher (Nephron Research): Inquired about health system purchasing behavior in response to tariffs and whether inventory or consumables strategies had shifted. Management indicated no significant stockpiling, emphasizing data-driven decision-making and contract protections.
• Michael Cherny (Leerink Partners): Sought clarity on fee share negotiations and whether outcomes were in line with expectations. Management said negotiations were ahead of schedule with fee share percentages as anticipated.
• Jessica Tassan (Piper Sandler): Questioned the impact of tariffs on operating versus capital expenses and Premier’s ability to source domestically. Management explained strategies are in place for both, but the mix is dynamic and shifts with industry conditions.
• Allen Lutz (Bank of America): Asked if customer behavior in the next quarter would mirror the current environment. Management noted ongoing pressure from tariffs and labor issues could temper customer outlooks.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will watch for (1) further progress on contract renewals and stabilization of supply chain fee structures, (2) evidence of margin benefits from new technology and advisory service investments, and (3) how effectively Premier’s tariff mitigation strategies protect both customers and the company. Additionally, the upcoming Epic partnership rollout and continued talent recruitment will serve as markers for Premier’s execution on its technology and growth ambitions.

Premier currently trades at a forward P/E ratio of 17.2×. Should you double down or take your chips? Find out in our free research report.

Stocks That Trumped Tariffs in 2018

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.